Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Enbridge Adding Canadian Egress to Key U.S. Refining Markets, Enhancing North American Energy Security
-
NMG's Matawinie Mine recognized as a “Major Project of National Interest” by the Government of Canada
-
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
-
HASI Prices Offering of $500 Million of Green Junior Subordinated Notes
-
DAWNZERA™ (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)
-
LITTLE BROWN JUG BRASS Presents 'Christmas In New Orleans' from the upcoming album HOLIDAY SPIRITS
-
Beyond Meat Announces Determination of Conversion Rate for 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030
-
Legence Announces Agreement to Acquire Bowers
-
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
-
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
-
Phononic Unleashes AI Data Center Performance Via Advanced Cooling With the Phononic ‘Thermal Kit’
-
Calisa Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
-
OTC Markets Group Welcomes Frontera Energy Corporation to OTCQX
-
GlobalFoundries to Host Inaugural Business and Strategy Webinar
-
Nokia Corporation - Managers' transactions (Uitto)
-
Nokia Corporation - Managers' transactions (Sahgal)
-
Nokia Corporation - Managers' transactions (Fisk)
-
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery
-
NexLiving Communities Reports Record Q3 2025 Results and Declares Quarterly Dividend
-
Bybit x Block Scholes Report: Crypto Positioning Forewarned Bitcoin Bear Market
-
Update on Phase 3 Librexia ACS Trial
-
Nidec Announces the Record of Provisions for Loss on Contract, Impairment Losses on Non-Financial Assets, and Liabilities Related to the Settlement of Claims From Suppliers
-
AMG Announces Conversion Rate Adjustment for its 5.15% Junior Convertible Trust Preferred Securities Due 2037
-
Nidec Announces Disclaimer of Conclusion in the Interim Review Report Concerning the Semi-annual Report for the Six Months Ended September 30, 2025
-
Nidec Announces Financial Results for Fiscal First Quarter Ended June 30, 2025
-
Search Minerals Completes Convertible Loan Transaction
-
A Global Point of View: The Money around the World with Elizabeth Fraley Kinder Ready
-
CTO Realty Growth Provides Leasing Update at the Shops at Legacy
-
Best Instant Cash Advance Loans for Bad Credit No Credit Check, Introduced by MoneyMutual
-
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
-
United Breast Cancer Foundation Launches 3-Tiered Digital Billboard in Times Square to Mark 25th Anniversary
-
Director/PDMR Shareholding
-
Weekly Recap: 15 Health Press Releases You Need to See
-
Bitget Wallet Expands Gas Abstraction to Morph with EIP‑7702
-
Form 8.3 - AXA INVESTMENT MANAGERS: Big Yellow Group plc
-
AIRO Reports Third Quarter 2025 Results; Progress on Drone Deliveries and Strong Liquidity Position
-
Weekly Recap: 12 Finance Press Releases You Need to See
-
Deepsnitch AI News: 21Shares Launches Crypto ETFs, Traders Rush Toward Deepsnitch AI’s $527K Presale
-
Best Financial Management Software (2025): QuickBooks Ranked #1 for Growing Business Success by Expert Consumers
-
The Dallas Morning News Recognizes MUFG Capital Analytics Among the Top Workplaces in Dallas-Fort Worth for 2025
-
American Bitcoin Reports Third Quarter 2025 Results
-
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
-
Vertiv Declares Quarterly Dividend
-
AIRO and Nord-Drone Execute Joint Venture to Deliver Battlefield-Tested Drone Technologies Across U.S., NATO, and Ukraine Defense Forces
-
Teleflex to Present at the Jefferies Global Healthcare Conference in London
-
Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes
-
CORRECTION - Vallourec – Convening of the General Meeting of Warrant Holders
-
Orion receives award for international growth from the President of the Republic of Finland
-
Form 8.5 (EPT/RI) - Team Plc
